Psoriasis drugs market in the United States by therapy class 2016-2022

This statistic shows the psoriasis drugs market in the United States from 2016 to 2022, by therapy class. Psoriasis is a chronic and common disease that is characteristic of red, scaly patches that forms on the skin all over the body. The disease is mediated by the immune system. The largest therapy class within the psoriasis market by 2022 is expected to be interleukin inhibitors, with some 4.4 billion U.S. dollars.

Psoriasis drugs market in the United States from 2016 to 2022, by therapy class

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until June 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

March 2019

Region

United States

Survey time period

as of September 2018

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical market in Italy"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.